Skip to main content
. 2022 May 10;12(5):e048478. doi: 10.1136/bmjopen-2020-048478

Figure 4.

Figure 4

Fitted metaregression line of the relationship between trial-level PrEP adherence and efficacy. Only trials that reported plasma drug concentration from a representative sample contributed to the analysis, represented as circles (Baeten 201218 (Partners PrEP), Choopanya 201315 (Bangkok Tenofovir Study), Grant 20103 (iPrEx), Mazzarro 201519 (VOICE), McCormack 20156 (PROUD), Molina 20155 (IPERGAY) and Van Damme 20127 (FEM-PrEP)). The solid line represents the fitted regression line and the shaded area represents the 95% CI. The X-axis represents the trial-level adherence as a proportion, and the Y-axis represents the efficacy as rate ratios. PrEP, pre-exposure prophylaxis.